Intervacc logo

Intervacc Investor Relations Material

Intervacc AB, a biotechnology company, engages in the research and development of veterinary vaccines using recombinant proteins for animal health. The company offers Canvax, a vaccine for bovine viral diarrhea; and Fervac B, a vaccine for feline viral rhinotracheitis, calicivirus, and panleukopenia. It also provides a range of potential prevention vaccines to veterinarians, including vaccines to control rabies. Intervacc is based in Hägersten, Sweden

Upcoming events for

Q3 20222022-11-10
Q2 20222022-08-31

Latest company events

Ticker symbol

IVACC

Country

Sweden

About the company

http://intervacc.se/

Investor Relations Page

http://intervacc.se/investerare/

Dig deeper into the Intervacc fundamentals on Quartr.

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
App store link
Android play link
Quartr app screenshot